About Us

Scientific Board

The Scientific Advisory Board is comprised of some of the nation’s leading physicians and research scientists from prominent universities and cancer centers. The Board ensures that all proposals meet the highest standards of scientific merit and that funding is properly allocated.  By focusing on brilliant young investigators, the Board works toward accomplishing the goal of the foundation: eradicating cancer.

Martin D. Abeloff, M.D.

In Memoriam

 


Robert C. Bast, Jr., M.D.

Vice President for Translational Research
MD Anderson Cancer Center 
Houston, TX


William T. Beck, Ph.D.

Professor and Head
Department of Biopharmaceutical Sciences 
University of Illinois at Chicago
Chicago, IL


Gerold Bepler, M.D., Ph.D.

President and CEO 
Karmanos Cancer Institute
Detroit, MI


Nancy Davidson, M.D. 

Director
University of Pittsburgh Cancer Institute
Pittsburgh, PA


H. Shelton Earp III, M.D.

Director & Lineberger Professor
Professor of Medicine and Pharmacology
UNC Lineberger Comprehensive Cancer Center 
Chapel Hill, NC


Paul F. Engstrom, M.D.

Senior Vice President for Population Science
Fox Chase Cancer Center
Philadelphia, PA


Olivera J. Finn, Ph.D.

Professor & Chair, Dept. of Immunology
University of Pittsburgh School of Medicine
Pittsburgh, PA


Richard I. Fisher, M.D.

Samuel E. Durand Professor of Medicine
Director, James P. Wilmot Cancer Center
Director, University of Rochester Medical Faculty Group
University of Rochester Medical Center
Rochester, NY


James M. Ford, M.D.

Associate Professor of Medicine and Genetics
Stanford University School of Medicine
Stanford, CA


Lynn M. Matrisian, Ph.D.

Professor and Chair, Department of Cancer Biology
Vanderbilt-Ingram Cancer Center
Nashville, TN


John D. Minna, M.D.  

Professor and Director, Hamon Center for Therapeutic Oncology Research 
Professor, Internal Medicine & Pharmacology
Director, Center for Cancer Genetics
University of Texas Southwestern Medical Center 
Dallas, TX


Joseph O. Moore, M.D.

Medical Director
Duke Raleigh Cancer Center
Professor, Hematology and Oncology
Duke Cancer Institute
Durham, NC


William G. Nelson, M.D., Ph.D.

Professor, Oncology and Urology Director 
Sidney Kimmel Comprehensive Cancer Center at John Hopkins
Baltimore, MD


Brian Patrick O’Neill, M.D. 

Professor of Neurology, Mayo Clinic College of Medicine
Leader, Translational Research Program in Neuro-Oncology
Director, Mayo SPORE in Brain Cancer
Mayo Clinic Cancer Center
Rochester, MN


Richard O’Reilly, M.D.

Chair, Department of Pediatrics
Chief, Pediatric Bone Marrow
Transplant Services
Memorial Sloan-Kettering Cancer Center
New York, NY


Jerome Ritz, M.D.

Professor of Medicine, Harvard Medical School
Dana-Farber Cancer Institute
Boston, MA


David E. Schuller, M.D.

Vice President, Medical Center Expansion and Outreach
CEO Emeritus 
James Cancer Hospital and Solove Research Institute
The Ohio State University
Columbus, OH


Jonathan W. Simons, M.D.

Chief Executive Officer
Prostate Cancer Foundation
Santa Monica, CA


Margaret A. Tempero, M.D.

Chief, Medical Oncology
Department of Medicine 
University of Calilfornia at San Francisco
San Francisco, CA


Daniel D. Von Hoff, M.D. 

Translational Genomics Research Institute
Phoenix, AZ